
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+3
Acute kidney injury (AKI) is a common clinical syndrome among hospitalized patients, affecting 1 in 5 adults and 1 in 4 children in the US. It is often asymptomatic and can be difficult to identify, yet it can have severe consequences. To learn more about this public health concern, visit https://bioporto.us/aki/. Located outside Boston, BioPorto Diagnostics is focused on saving lives and improving the quality of life with actionable biomarkers tools designed to help clinicians make changes in patient management. FDA-cleared ProNephro AKITM (NGAL) is designed to aid in AKI risk assessment in pediatric patients 3 months to <22 years...
Ngal research,ngal elisa kits (human and animal),kidney disease research,pre-clinical / non-clinical research,clinical research,drug induced kidney injury (diki),fda qualified biomarker (bqp),and scientific and pre-clinical drug research
Bioporto diagnostics inc. (us) operates in the Biotechnology research industry.
Bioporto diagnostics inc. (us)'s revenue is 11m - 100m
Bioporto diagnostics inc. (us) has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.